nodes	percent_of_prediction	percent_of_DWPC	metapath
Lornoxicam—PTGS2—head and neck cancer	0.992	1	CbGaD
Lornoxicam—Tenoxicam—PTGS2—head and neck cancer	0.00327	0.429	CrCbGaD
Lornoxicam—Meloxicam—PTGS2—head and neck cancer	0.00233	0.306	CrCbGaD
Lornoxicam—Piroxicam—PTGS2—head and neck cancer	0.00202	0.265	CrCbGaD
